Navigation Links
Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations

Andrew Raguskus to Serve as Senior Technology Advisor

SALT LAKE CITY, May 13 /PRNewswire-FirstCall/ -- The Board of Directors of Sonic Innovations, Inc. (Nasdaq: SNCI), a leading producer of advanced digital hearing aids, today announced that Andrew Raguskus has stepped down as Chairman of the Board. Mr. Raguskus will continue as a member of the Board of Directors and serve as its Senior Technology Advisor. As a result of Mr. Raguskus' announcement, the Board of Directors appointed CEO Sam Westover to serve as Chairman of the Board and Chief Executive Officer for the company.

James Callahan will continue to serve as Lead Independent Director for the Board of Directors. Mr. Callahan has been a director for the company since 2004 and was reelected for an additional three year term at this year's annual shareholders meeting. He is also a member of the Board's Audit and Compensation Committees.

In making his announcement, Mr. Raguskus stated, "When I was asked to serve as Chairman of the Board it was with the intention of giving Sam [Westover] time to focus his attention on the strategy and operations of the business. He has clearly set the company on the right path and, therefore, it is time for me to step aside and allow him to assume full leadership responsibility for the company."

"Andy has been a tremendous asset to this company and the Board and I have the utmost respect for his leadership and accomplishments," said Mr. Westover in response to his appointment as Chairman of the Board. "Sonic would not be celebrating its 10-year anniversary were it not for his commitment to developing and delivering the best hearing instruments. I am pleased that Andy has agreed to accept the role of Senior Technical Advisor. His knowledge and insight to the hearing aid industry will be invaluable as we continue to develop new products to meet the needs of our customers."

About Sonic Innovations

Sonic Innovations, Inc. is the largest, publicly traded U.S.-based hearing aid manufacturer. The company was founded with a mission to commercialize a unique digital signal processing platform for hearing aids. Sonic Innovations hearing aids were among the first of their kind clinically proven to increase speech understanding in noise for the hearing impaired. Sonic Innovations, headquartered in Salt Lake City, is listed on the NASDAQ Global Market System and can be found online at

This press release may contain "forward-looking statements" as defined under securities laws. Actual results may differ materially and adversely from those described herein depending on a number of factors including, but not limited to, the following risks: we face aggressive competition in our business; acquisitions could be difficult to integrate and disrupt our current business and therefore may harm our operating results; we may poorly operate newly acquired businesses; we may lose a large customer or suffer a reduction in orders from a large customer; we must have innovative, technologically superior products to compete effectively; our products, due to their complexity, may contain errors or defects that are only discovered after sales by our customers, thus harming our reputation and business; we may have issues with intellectual property; and we have important international operations, which expose us to a variety of risks including government reimbursement, that could impact sales and operating results. For additional information regarding the risks inherent in our business, please see "Factors That May Affect Future Performance" included in our Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.

SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chrysler LLC Vice Chairman and President Jim Press and His Wife Suwichada Serve as Honorary Co-Chairs of Annual Juvenile Diabetes Research Foundation Promise Ball
2. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
3. End-stage dementia patients deserve the same access to palliative care as people with cancer
4. VA-DoD Program Serves Severely Disabled Combat Veterans
5. Warren F. Muth, MD, to Serve as President of Ohio State Medical Association
6. ACC Observes National Drinking Water Week
7. New Report: Increasing Ohios Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program
8. Old Orchard Introduces First Multi-Serve Vitamin Water, Sweetened with Agave Nectar and Real Fruit Juice
9. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
10. Cynthia Nixon to Serve as Ambassador for Susan G. Komen for the Cure(R)
11. Want docs to treat the underserved? Make sure they train at community health centers
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy ... personal heating products business. Cozy Products explains what this means for business moving ... well with the Cozy Products business model: to sell personal heaters that reduce energy ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 AAIPharma Services Corp./Cambridge ... of at least $15.8  Million to expand its ... NC . The expansion will provide additional ... the growing demands of the pharmaceutical and biotechnology ... expansion will provide up to 40,000 square feet ...
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: